Search

Your search keyword '"Marc Vidal"' showing total 392 results

Search Constraints

Start Over You searched for: Author "Marc Vidal" Remove constraint Author: "Marc Vidal"
392 results on '"Marc Vidal"'

Search Results

1. AI-guided pipeline for protein–protein interaction drug discovery identifies a SARS-CoV-2 inhibitor

2. Paired yeast one-hybrid assays to detect DNA-binding cooperativity and antagonism across transcription factors

3. Knee flexion of saxophone players anticipates tonal context of music

4. Next-generation large-scale binary protein interaction network for Drosophila melanogaster

5. Assessment of community efforts to advance network-based prediction of protein–protein interactions

6. Homo cerevisiae—Leveraging Yeast for Investigating Protein–Protein Interactions and Their Role in Human Disease

7. ORF Capture-Seq as a versatile method for targeted identification of full-length isoforms

8. A proactive genotype-to-patient-phenotype map for cystathionine beta-synthase

9. Author Correction: Protein interaction network of alternatively spliced isoforms from brain links genetic risk factors for autism

10. The HTLV-1 viral oncoproteins Tax and HBZ reprogram the cellular mRNA splicing landscape.

11. A genome-wide positioning systems network algorithm for in silico drug repurposing

12. Maximizing binary interactome mapping with a minimal number of assays

13. Network-based prediction of protein interactions

14. A framework for exhaustively mapping functional missense variants

15. Global Analysis of Intercellular Homeodomain Protein Transfer

16. Bi-Smoothed Functional Independent Component Analysis for EEG Artifact Removal

17. An inter‐species protein–protein interaction network across vast evolutionary distance

18. Pooled‐matrix protein interaction screens using Barcode Fusion Genetics

19. Network-based in silico drug efficacy screening

20. Yeast-Based Genetic Interaction Analysis of Human Kinome

21. Domain-based prediction of the human isoform interactome provides insights into the functional impact of alternative splicing.

22. Identifying pathogenicity of human variants via paralog-based yeast complementation.

23. A Chaperome Subnetwork Safeguards Proteostasis in Aging and Neurodegenerative Disease

24. Protein domain-level landscape of cancer-type-specific somatic mutations.

25. Mycobacterium tuberculosis type VII secreted effector EsxH targets host ESCRT to impair trafficking.

26. SH3 interactome conserves general function over specific form

27. Viral perturbations of host networks reflect disease etiology.

28. Identification of FAM111A as an SV40 host range restriction and adenovirus helper factor.

29. Evidence for transcript networks composed of chimeric RNAs in human cells.

30. Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer.

31. A genome-wide gene function prediction resource for Drosophila melanogaster.

32. RNAi screening implicates a SKN-1-dependent transcriptional response in stress resistance and longevity deriving from translation inhibition.

34. Bayesian modeling of the yeast SH3 domain interactome predicts spatiotemporal dynamics of endocytosis proteins.

36. Intrinsic disorder is a common feature of hub proteins from four eukaryotic interactomes.

37. Abstract P4-08-21: Development of novel inhibitors of the serum/glucocorticoid induced kinase (SGK) family to address limitations of AKT/PI3K/mTOR inhibitors in breast cancer

39. Talking Cars, Doubtful Users-A Population Study in Virtual Reality

41. Data from MECP2 Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in Malignancy

42. Supplementary Data from MECP2 Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in Malignancy

43. Supplementary Figures S1 - S6 from MECP2 Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in Malignancy

44. Supplementary Tables S1 - S3 from MECP2 Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in Malignancy

45. Supplementary Methods from MECP2 Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in Malignancy

47. Supplementary Methods and Figure Legends (Fig. S2 legend revised 8/31/09) from Multimodal Assessment of Protein Functional Deficiency Supports Pathogenicity of BRCA1 p.V1688del

50. Novel whitening approaches in functional settings

Catalog

Books, media, physical & digital resources